In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. (Q39671711)

From Wikidata
Jump to: navigation, search
scientific article published on 16 June 2016
edit
Language Label Description Also known as
English
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.
scientific article published on 16 June 2016

    Statements

    In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. (English)
    Alessandro Carugo
    Giannicola Genovese
    Sahil Seth
    Luigi Nezi
    Johnathon Lynn Rose
    Daniela Bossi
    Angelo Cicalese
    Parantu Krushnakant Shah
    Andrea Viale
    Piergiorgio Francesco Pettazzoni
    Kadir Caner Akdemir
    Christopher Aaron Bristow
    Frederick Scott Robinson
    James Tepper
    Nora Sanchez
    Sonal Gupta
    Marcos Roberto Estecio
    Virginia Giuliani
    Gaetano Ivan Dellino
    Laura Riva
    Wantong Yao
    Maria Emilia Di Francesco
    Tessa Green
    Carolina D'Alesio
    Denise Corti
    Ya'an Kang
    Philip Jones
    Huamin Wang
    Jason Bates Fleming
    Anirban Maitra
    Pier Giuseppe Pelicci
    Lynda Chin
    Ronald Anthony DePinho
    Luisa Lanfrancone
    Timothy Paul Heffernan
    Giulio Francesco Draetta
    16 June 2016
    133-147

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit